Aetna · Clinical coverage policy

Aetna Septoplasty and Rhinoplasty coverage criteria

Aetna covers septoplasty for specific functional indications (e.g., access for other surgery, recurrent deviation-related sinusitis or epistaxis, or continuous airway obstruction unresponsive to 4+ weeks of medical therapy) and covers rhinoplasty only in limited circumstances such as congenital cleft lip/palate deformity, nasal dermoid removal, or—on individual case review—vestibular stenosis or as an integral part of a medically necessary septoplasty when strict criteria and documentation are met. Rhinoplasty is otherwise considered cosmetic, and numerous newer techniques (e.g., septal swell body ablation, balloon septoplasty, nasal valve suspension, Spirox Latera implant) are experimental/investigational.

Policy CPB 0005 · Effective · Verify against the current Aetna policy before submitting — view source policy.

Payer

Aetna

Policy

CPB 0005

Prior auth

Confirm

Effective

January 1, 2026

This page reflects the coverage criteria captured from Aetna policy CPB 0005 and may not include every criterion, exception, or code — verify the complete bulletin before submitting.

What this means for the claim

The covered path, the next step to get it approved, and the specific way it denies — built only from this policy.

When does Aetna cover Septoplasty and Rhinoplasty (CPT 30520), and what gets it denied?

Path
Aetna covers septoplasty for specific functional indications (e.g., access for other surgery, recurrent deviation-related sinusitis or epistaxis, or continuous airway obstruction unresponsive to 4+ weeks of medical therapy) and covers rhinoplasty only in limited circumstances such as congenital cleft lip/palate deformity, nasal dermoid removal, or—on individual case review—vestibular stenosis or as an integral part of a medically necessary septoplasty when strict criteria and documentation are met. Rhinoplasty is otherwise considered cosmetic, and numerous newer techniques (e.g., septal swell body ablation, balloon septoplasty, nasal valve suspension, Spirox Latera implant) are experimental/investigational. Coverage criteria include: Septoplasty is medically necessary when ANY ONE of the following is met: (a) Asymptomatic septal deformity that prevents access to other intranasal areas when such access is required to perform medically necessary surgical procedures (e.g., ethmoidectomy); OR (b) Documented recurrent sinusitis felt to be due to a deviated septum not relieved by appropriate medical and antibiotic therapy; OR (c) Recurrent epistaxis (nose-bleeds) related to a septal deformity; OR (d) Septal deviation causing continuous nasal airway obstruction resulting in nasal breathing difficulty not responding to 4 or more weeks of appropriate medical therapy; OR (e) When done in association with cleft palate repair; Extracorporeal septoplasty is medically necessary for INITIAL correction of an extremely deviated nasal septum that cannot adequately be corrected with an intranasal approach, for members who meet the criteria for septoplasty listed above; Rhinoplasty is medically necessary when it is being performed to correct a nasal deformity secondary to congenital cleft lip and/or palate, OR for removal of a nasal dermoid; Rhinoplasty is medically necessary, upon individual case review, to correct chronic non-septal nasal airway obstruction from vestibular stenosis (collapsed internal valves) due to trauma, disease, or congenital defect, when ALL of the following are met: Prolonged, persistent obstructed nasal breathing; AND Physical examination confirming moderate to severe vestibular obstruction; AND Airway obstruction will not respond to septoplasty and turbinectomy alone; AND Nasal airway obstruction is causing significant symptoms (e.g., chronic rhinosinusitis, difficulty breathing); AND Obstructive symptoms persist despite conservative management for 4 weeks or greater, which includes, where appropriate, nasal steroids or immunotherapy; AND Photographs demonstrate an external nasal deformity; AND There is significant obstruction of one or both nares, documented by nasal endoscopy, computed tomography (CT) scan or other appropriate imaging modality; Rhinoplasty for nasal airway obstruction is medically necessary when performed as an integral part of a medically necessary septoplasty AND there is documentation of gross nasal obstruction on the same side as the septal deviation; Nasal septal button for non-surgical closure of septal perforations is medically necessary (no sub-criteria listed); Repair of nasal septal perforations is medically necessary (no sub-criteria listed); Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Cautery or arterial ligation for recurrent epistaxis refractory to initial local measures; Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Necrotizing lesions (from infection, vasculitis, or drug abuse); Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of benign masses (e.g., inverted papilloma, juvenile angiofibroma, nasal glial heterotopias, dermoids, pyogenic granuloma, polyps) causing obstruction; Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of isolated intra-nasal malignancies (e.g., intranasal basal cell carcinoma); Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of locally aggressive or destructive lesions such as schwannomas, fibro-osseous lesions, pleomorphic adenomas, and hereditary hemorrhagic telangiectasia; Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of other masses (excluding septal swell bodies) causing obstruction, airway compromise or pain interfering with quality of life; Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of retained foreign bodies not amenable to external removal; Under many Aetna plans, surgery to correct deformity due to an injury is covered when it is performed in the calendar year of the accident that causes the injury or in the next calendar year (members should check benefit plan descriptions for details). Applies to 8 codes: 30520, 30620, 30220, 30630, 30124, 30125, 30460, 30462.
Action
Confirm prior-authorization status with Aetna before scheduling — it is code- and plan-specific, and this policy is not an exact authorization source. Documentation: For rhinoplasty criteria 2 (vestibular stenosis) and 3 (integral to septoplasty): The duration and degree of symptoms related to nasal obstruction, such as chronic rhinosinusitis, mouth breathing, etc.; The results of conservative management of symptoms; If there is an external nasal deformity, pre-operative photographs showing the standard 4-way view: anterior-posterior, right and left lateral views, and base of nose (also known as worm's eye view confirming vestibular stenosis; this view is from the bottom of nasal septum pointing upwards); Relevant history of accidental or surgical trauma, congenital defect, or disease (e.g., Wegener's granulomatosis, choanal atresia, nasal malignancy, abscess, septal infection with saddle deformity, or congenital deformity); Results of nasal endoscopy, CT or other appropriate imaging modality documenting degree of nasal obstruction.
Trap
Policy exclusions and limitations: Septoplasty is experimental, investigational, or unproven for all other indications (e.g., allergic rhinitis) because its effectiveness other than the ones listed has not been established; Rhinoplasty is considered cosmetic for all other indications (i.e., indications other than the medically necessary circumstances listed); Ablation, excision or destruction of septal swell bodies for the treatment of chronic rhinitis, chronic sinusitis, or nasal obstruction is experimental, investigational, or unproven; Balloon septoplasty for the treatment for nasal fracture and septal deviation is experimental, investigational, or unproven; Extracorporeal septoplasty for revision of deviated septum is experimental, investigational, or unproven; Nasal valve suspension for the repair of nasal valve collapse is experimental, investigational, or unproven; Pyriform aperture reduction (pyriform turbinoplasty) for the treatment of nasal obstruction is experimental, investigational, or unproven; Use of absorbable nasal implant (e.g., the Spirox Latera Absorbable Nasal Implant) for nasal valve reconstruction, treatment of nasal valve weakness, and for all other indications is experimental, investigational, or unproven; Use of blood products (e.g., concentrated growth factor or platelet-rich fibrin) with diced cartilage in rhinoplasty is experimental, investigational, or unproven; Use of concentrated growth factor extracted from blood plasma for repair of nasal septal mucosal defect following rhinoplasty is experimental, investigational, or unproven. Claims may be denied when the requested service falls under these.

Source: Aetna CPB 0005 — Septoplasty and Rhinoplasty

Coverage criteria

  • Septoplasty is medically necessary when ANY ONE of the following is met: (a) Asymptomatic septal deformity that prevents access to other intranasal areas when such access is required to perform medically necessary surgical procedures (e.g., ethmoidectomy); OR (b) Documented recurrent sinusitis felt to be due to a deviated septum not relieved by appropriate medical and antibiotic therapy; OR (c) Recurrent epistaxis (nose-bleeds) related to a septal deformity; OR (d) Septal deviation causing continuous nasal airway obstruction resulting in nasal breathing difficulty not responding to 4 or more weeks of appropriate medical therapy; OR (e) When done in association with cleft palate repair
  • Extracorporeal septoplasty is medically necessary for INITIAL correction of an extremely deviated nasal septum that cannot adequately be corrected with an intranasal approach, for members who meet the criteria for septoplasty listed above
  • Rhinoplasty is medically necessary when it is being performed to correct a nasal deformity secondary to congenital cleft lip and/or palate, OR for removal of a nasal dermoid
  • Rhinoplasty is medically necessary, upon individual case review, to correct chronic non-septal nasal airway obstruction from vestibular stenosis (collapsed internal valves) due to trauma, disease, or congenital defect, when ALL of the following are met: Prolonged, persistent obstructed nasal breathing; AND Physical examination confirming moderate to severe vestibular obstruction; AND Airway obstruction will not respond to septoplasty and turbinectomy alone; AND Nasal airway obstruction is causing significant symptoms (e.g., chronic rhinosinusitis, difficulty breathing); AND Obstructive symptoms persist despite conservative management for 4 weeks or greater, which includes, where appropriate, nasal steroids or immunotherapy; AND Photographs demonstrate an external nasal deformity; AND There is significant obstruction of one or both nares, documented by nasal endoscopy, computed tomography (CT) scan or other appropriate imaging modality
  • Rhinoplasty for nasal airway obstruction is medically necessary when performed as an integral part of a medically necessary septoplasty AND there is documentation of gross nasal obstruction on the same side as the septal deviation
  • Nasal septal button for non-surgical closure of septal perforations is medically necessary (no sub-criteria listed)
  • Repair of nasal septal perforations is medically necessary (no sub-criteria listed)
  • Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Cautery or arterial ligation for recurrent epistaxis refractory to initial local measures
  • Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Necrotizing lesions (from infection, vasculitis, or drug abuse)
  • Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of benign masses (e.g., inverted papilloma, juvenile angiofibroma, nasal glial heterotopias, dermoids, pyogenic granuloma, polyps) causing obstruction
  • Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of isolated intra-nasal malignancies (e.g., intranasal basal cell carcinoma)
  • Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of locally aggressive or destructive lesions such as schwannomas, fibro-osseous lesions, pleomorphic adenomas, and hereditary hemorrhagic telangiectasia
  • Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of other masses (excluding septal swell bodies) causing obstruction, airway compromise or pain interfering with quality of life
  • Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of retained foreign bodies not amenable to external removal
  • Under many Aetna plans, surgery to correct deformity due to an injury is covered when it is performed in the calendar year of the accident that causes the injury or in the next calendar year (members should check benefit plan descriptions for details)

Covered codes

Codes listed in this Aetna policy. Check each one's prior-authorization verdict and Medicare rate:

Documentation required

  • For rhinoplasty criteria 2 (vestibular stenosis) and 3 (integral to septoplasty): The duration and degree of symptoms related to nasal obstruction, such as chronic rhinosinusitis, mouth breathing, etc.
  • The results of conservative management of symptoms
  • If there is an external nasal deformity, pre-operative photographs showing the standard 4-way view: anterior-posterior, right and left lateral views, and base of nose (also known as worm's eye view confirming vestibular stenosis; this view is from the bottom of nasal septum pointing upwards)
  • Relevant history of accidental or surgical trauma, congenital defect, or disease (e.g., Wegener's granulomatosis, choanal atresia, nasal malignancy, abscess, septal infection with saddle deformity, or congenital deformity)
  • Results of nasal endoscopy, CT or other appropriate imaging modality documenting degree of nasal obstruction

Frequently asked questions

When does Aetna cover Septoplasty and Rhinoplasty (CPT 30520), and what gets it denied?
Aetna covers septoplasty for specific functional indications (e.g., access for other surgery, recurrent deviation-related sinusitis or epistaxis, or continuous airway obstruction unresponsive to 4+ weeks of medical therapy) and covers rhinoplasty only in limited circumstances such as congenital cleft lip/palate deformity, nasal dermoid removal, or—on individual case review—vestibular stenosis or as an integral part of a medically necessary septoplasty when strict criteria and documentation are met. Rhinoplasty is otherwise considered cosmetic, and numerous newer techniques (e.g., septal swell body ablation, balloon septoplasty, nasal valve suspension, Spirox Latera implant) are experimental/investigational. Coverage criteria include: Septoplasty is medically necessary when ANY ONE of the following is met: (a) Asymptomatic septal deformity that prevents access to other intranasal areas when such access is required to perform medically necessary surgical procedures (e.g., ethmoidectomy); OR (b) Documented recurrent sinusitis felt to be due to a deviated septum not relieved by appropriate medical and antibiotic therapy; OR (c) Recurrent epistaxis (nose-bleeds) related to a septal deformity; OR (d) Septal deviation causing continuous nasal airway obstruction resulting in nasal breathing difficulty not responding to 4 or more weeks of appropriate medical therapy; OR (e) When done in association with cleft palate repair; Extracorporeal septoplasty is medically necessary for INITIAL correction of an extremely deviated nasal septum that cannot adequately be corrected with an intranasal approach, for members who meet the criteria for septoplasty listed above; Rhinoplasty is medically necessary when it is being performed to correct a nasal deformity secondary to congenital cleft lip and/or palate, OR for removal of a nasal dermoid; Rhinoplasty is medically necessary, upon individual case review, to correct chronic non-septal nasal airway obstruction from vestibular stenosis (collapsed internal valves) due to trauma, disease, or congenital defect, when ALL of the following are met: Prolonged, persistent obstructed nasal breathing; AND Physical examination confirming moderate to severe vestibular obstruction; AND Airway obstruction will not respond to septoplasty and turbinectomy alone; AND Nasal airway obstruction is causing significant symptoms (e.g., chronic rhinosinusitis, difficulty breathing); AND Obstructive symptoms persist despite conservative management for 4 weeks or greater, which includes, where appropriate, nasal steroids or immunotherapy; AND Photographs demonstrate an external nasal deformity; AND There is significant obstruction of one or both nares, documented by nasal endoscopy, computed tomography (CT) scan or other appropriate imaging modality; Rhinoplasty for nasal airway obstruction is medically necessary when performed as an integral part of a medically necessary septoplasty AND there is documentation of gross nasal obstruction on the same side as the septal deviation; Nasal septal button for non-surgical closure of septal perforations is medically necessary (no sub-criteria listed); Repair of nasal septal perforations is medically necessary (no sub-criteria listed); Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Cautery or arterial ligation for recurrent epistaxis refractory to initial local measures; Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Necrotizing lesions (from infection, vasculitis, or drug abuse); Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of benign masses (e.g., inverted papilloma, juvenile angiofibroma, nasal glial heterotopias, dermoids, pyogenic granuloma, polyps) causing obstruction; Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of isolated intra-nasal malignancies (e.g., intranasal basal cell carcinoma); Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of locally aggressive or destructive lesions such as schwannomas, fibro-osseous lesions, pleomorphic adenomas, and hereditary hemorrhagic telangiectasia; Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of other masses (excluding septal swell bodies) causing obstruction, airway compromise or pain interfering with quality of life; Excision or destruction of intranasal lesions using an internal approach is medically necessary for: Removal of retained foreign bodies not amenable to external removal; Under many Aetna plans, surgery to correct deformity due to an injury is covered when it is performed in the calendar year of the accident that causes the injury or in the next calendar year (members should check benefit plan descriptions for details). Applies to 8 codes: 30520, 30620, 30220, 30630, 30124, 30125, 30460, 30462. Confirm prior-authorization status with Aetna before scheduling — it is code- and plan-specific, and this policy is not an exact authorization source. Documentation: For rhinoplasty criteria 2 (vestibular stenosis) and 3 (integral to septoplasty): The duration and degree of symptoms related to nasal obstruction, such as chronic rhinosinusitis, mouth breathing, etc.; The results of conservative management of symptoms; If there is an external nasal deformity, pre-operative photographs showing the standard 4-way view: anterior-posterior, right and left lateral views, and base of nose (also known as worm's eye view confirming vestibular stenosis; this view is from the bottom of nasal septum pointing upwards); Relevant history of accidental or surgical trauma, congenital defect, or disease (e.g., Wegener's granulomatosis, choanal atresia, nasal malignancy, abscess, septal infection with saddle deformity, or congenital deformity); Results of nasal endoscopy, CT or other appropriate imaging modality documenting degree of nasal obstruction. Policy exclusions and limitations: Septoplasty is experimental, investigational, or unproven for all other indications (e.g., allergic rhinitis) because its effectiveness other than the ones listed has not been established; Rhinoplasty is considered cosmetic for all other indications (i.e., indications other than the medically necessary circumstances listed); Ablation, excision or destruction of septal swell bodies for the treatment of chronic rhinitis, chronic sinusitis, or nasal obstruction is experimental, investigational, or unproven; Balloon septoplasty for the treatment for nasal fracture and septal deviation is experimental, investigational, or unproven; Extracorporeal septoplasty for revision of deviated septum is experimental, investigational, or unproven; Nasal valve suspension for the repair of nasal valve collapse is experimental, investigational, or unproven; Pyriform aperture reduction (pyriform turbinoplasty) for the treatment of nasal obstruction is experimental, investigational, or unproven; Use of absorbable nasal implant (e.g., the Spirox Latera Absorbable Nasal Implant) for nasal valve reconstruction, treatment of nasal valve weakness, and for all other indications is experimental, investigational, or unproven; Use of blood products (e.g., concentrated growth factor or platelet-rich fibrin) with diced cartilage in rhinoplasty is experimental, investigational, or unproven; Use of concentrated growth factor extracted from blood plasma for repair of nasal septal mucosal defect following rhinoplasty is experimental, investigational, or unproven. Claims may be denied when the requested service falls under these.
Does Aetna require prior authorization for Septoplasty and Rhinoplasty?
Confirm prior-authorization status with Aetna before scheduling — it is code- and plan-specific, and this policy is not an exact authorization source. Documentation: For rhinoplasty criteria 2 (vestibular stenosis) and 3 (integral to septoplasty): The duration and degree of symptoms related to nasal obstruction, such as chronic rhinosinusitis, mouth breathing, etc.; The results of conservative management of symptoms; If there is an external nasal deformity, pre-operative photographs showing the standard 4-way view: anterior-posterior, right and left lateral views, and base of nose (also known as worm's eye view confirming vestibular stenosis; this view is from the bottom of nasal septum pointing upwards); Relevant history of accidental or surgical trauma, congenital defect, or disease (e.g., Wegener's granulomatosis, choanal atresia, nasal malignancy, abscess, septal infection with saddle deformity, or congenital deformity); Results of nasal endoscopy, CT or other appropriate imaging modality documenting degree of nasal obstruction.
What does Aetna exclude for Septoplasty and Rhinoplasty?
Policy exclusions and limitations: Septoplasty is experimental, investigational, or unproven for all other indications (e.g., allergic rhinitis) because its effectiveness other than the ones listed has not been established; Rhinoplasty is considered cosmetic for all other indications (i.e., indications other than the medically necessary circumstances listed); Ablation, excision or destruction of septal swell bodies for the treatment of chronic rhinitis, chronic sinusitis, or nasal obstruction is experimental, investigational, or unproven; Balloon septoplasty for the treatment for nasal fracture and septal deviation is experimental, investigational, or unproven; Extracorporeal septoplasty for revision of deviated septum is experimental, investigational, or unproven; Nasal valve suspension for the repair of nasal valve collapse is experimental, investigational, or unproven; Pyriform aperture reduction (pyriform turbinoplasty) for the treatment of nasal obstruction is experimental, investigational, or unproven; Use of absorbable nasal implant (e.g., the Spirox Latera Absorbable Nasal Implant) for nasal valve reconstruction, treatment of nasal valve weakness, and for all other indications is experimental, investigational, or unproven; Use of blood products (e.g., concentrated growth factor or platelet-rich fibrin) with diced cartilage in rhinoplasty is experimental, investigational, or unproven; Use of concentrated growth factor extracted from blood plasma for repair of nasal septal mucosal defect following rhinoplasty is experimental, investigational, or unproven. Claims may be denied when the requested service falls under these.

Source

Aetna CPB 0005 — Septoplasty and Rhinoplasty

Related

Need this Aetna approval drafted?

Ask D3 builds the documentation checklist and a ready-to-send request from this policy's criteria — cited, free, no signup.

Ask D3 Free

Coverage disclaimer

This page summarizes Aetna clinical-coverage criteria extracted from policy CPB 0005 for educational purposes. Coverage policies change and vary by individual plan. Always verify against Aetna's current policy before performing a procedure or submitting a claim. d3rx is not responsible for claim denials or reimbursement issues.